The Alteration of Plasma Matrix Metalloproteinase-9 Level after the Addition of Bromelin 500 mg to Standard Therapy of Acute Ischemic Stroke and Its Correlation with Outcome

BACKGROUND: Matrix metalloproteinase-9 (MMP9) expression due to ischemic cause spreading of brain damage. Previous studies have reported that Bromelin was beneficial as anti-inflammation and prevent brain tissue damage. AIM: This study aimed to determine the alteration of plasma MMP9 level after add...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Access Maced J Med Sci
Autori principali: Sinurat, Puji Pinta, Sjahrir, Hasan, Rambe, Aldy S., Ganie, Ratna Akbari
Natura: Artigo
Lingua:Inglês
Pubblicazione: Republic of Macedonia 2018
Soggetti:
Clinical Science
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5927490/
https://ncbi.nlm.nih.gov/pubmed/29731927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2018.151
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi